ReviewInternational journal of molecular sciences2021

Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies.

Ivanna Hrynchak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.